A61K 49/0019
Characterised by the fluorescent group
Official title: {characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules}
A61K49/0019 (Characterised by the fluorescent group) appears on 2,211 US grants and 3,637 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,211
- Published applications
- 3,637
- Assignees
- 1,370
- Inventors
- 6,871
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 7 | 0 |
| 1992 | 8 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 14 | 0 |
| 1996 | 13 | 0 |
| 1997 | 17 | 0 |
| 1998 | 26 | 0 |
| 1999 | 21 | 0 |
| 2000 | 19 | 0 |
| 2001 | 38 | 10 |
| 2002 | 27 | 38 |
| 2003 | 20 | 68 |
| 2004 | 21 | 71 |
| 2005 | 20 | 72 |
| 2006 | 22 | 65 |
| 2007 | 28 | 87 |
| 2008 | 37 | 98 |
| 2009 | 28 | 127 |
| 2010 | 34 | 130 |
| 2011 | 56 | 170 |
| 2012 | 72 | 117 |
| 2013 | 85 | 165 |
| 2014 | 105 | 175 |
| 2015 | 107 | 182 |
| 2016 | 121 | 187 |
| 2017 | 161 | 210 |
| 2018 | 114 | 213 |
| 2019 | 166 | 195 |
| 2020 | 172 | 247 |
| 2021 | 135 | 207 |
| 2022 | 109 | 185 |
| 2023 | 107 | 183 |
| 2024 | 117 | 179 |
| 2025 | 93 | 148 |
| 2026 | 64 | 108 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Bimetallic fluorescent nanocomposites for cancer theranostics29 Sep 2026US 12,746,598 B2Council of Scientific and Industrial Research
- Methods and compositions for delivery of agents across the blood-brain barrier29 Sep 2026US 12,747,269 B2The Brigham and Women S Hospital, Inc.
- Probe directed to enzyme ALDH1A3 and use thereof in the diagnosis of glioblastoma15 Sep 2026US 12,734,254 B2Universita Degli Studi Del Piemonte Orientale “A. Avogadro”
- Heptamethine cyanine near-infrared fluorescent dye, preparation method therefor and use thereof8 Sep 2026US 12,728,173 B2Nanjing Nuoyuan Medical Devices Co., Ltd
- Method for treating cancerous tissue with a nanotherapeutic1 Sep 2026US 12,721,910 B2Imam Abdulrahman Bin Faisal University
- Fluorescein-labeled nerve targeting peptide formulations and related methods8 Oct 2026US 2026/0306676 A1Alume Biosciences, Inc.
- Method for detecting a gd2 positive cancer8 Oct 2026US 2026/0306677 A1Prinses Maxima Centrum Voor Kinderoncologie B.V.
- Voltage sensitive thiazolothiazole dyes and associated synthetic methods8 Oct 2026US 2026/0308176 A1
- Method for Medical Imaging1 Oct 2026US 2026/0294251 A1Integro Theranositcs, LLC
- Fluorescent sensors and methods of making and using1 Oct 2026US 2026/0295095 A1Howard Hughes Medical Institute
Most cited
By later US patents
- Method and device for detecting and quantifying glucose in body fluids905US 5,342,789 ASensor Technologies, Inc. · 1994
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors891US 8,008,088 B2Masimo Laboratories, Inc. · 2011
- Non-invasive measurement of analytes836US 8,509,867 B2Cercacor Laboratories, Inc. · 2013
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors707US 8,029,765 B2Masimo Laboratories, Inc. · 2011
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors651US 8,466,286 B2Cercacor Laboratories, Inc. · 2013